Basit öğe kaydını göster

dc.contributor.authorAydinli, Musa
dc.contributor.authorBayraktar, Yusuf
dc.date.accessioned2019-12-10T11:10:37Z
dc.date.available2019-12-10T11:10:37Z
dc.date.issued2007
dc.identifier.issn1007-9327
dc.identifier.urihttps://doi.org/10.3748/wjg.v13.i19.2693
dc.identifier.urihttp://hdl.handle.net/11655/14885
dc.description.abstractBudd-Chiari syndrome is a congestive hepatopathy caused by blockage of hepatic veins. This syndrome occurs in 1/100000 in the general population. Hypercoagulable state could be identified in 75% of the patients; more than one etiologic factor may play a role in 25% of the patients. Primary myeloproliferative diseases are the leading cause of the disease. Two of the hepatic veins must be blocked for clinically evident disease. Liver congestion and hypoxic damage of hepatocytes eventually result in predominantly centrilobular fibrosis. Doppler ultrasonography of the liver should be the initial diagnostic procedure. Hepatic venography is the reference procedure if required. Additionally liver biopsy may be helpful for differential diagnosis. The prognosis of the chronic form is acceptable compared to other chronic liver diseases. (C) 2007 The WJG Press. All rights reserved.
dc.language.isoen
dc.publisherW J G Press
dc.relation.isversionof10.3748/wjg.v13.i19.2693
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGastroenterology & Hepatology
dc.titleBudd-Chiari Syndrome: Etiology, Pathogenesis and Diagnosis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalWorld Journal Of Gastroenterology
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume13
dc.identifier.issue19
dc.identifier.startpage2693
dc.identifier.endpage2696
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster